These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8461269)

  • 1. Differential effects of haloperidol on negative symptoms in drug-naive schizophrenic patients: effects on plasma homovanillic acid.
    Labarca R; Silva H; Jerez S; Ruiz A; Forray MI; Gysling K; Andres ME; Bustos G; Castillo Y; Hono J
    Schizophr Res; 1993 Mar; 9(1):29-34. PubMed ID: 8461269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
    Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG
    Psychiatry Res; 1992 Mar; 41(3):191-202. PubMed ID: 1594706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
    Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL
    Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients.
    Suzuki E; Kanba S; Nibuya M; Adachi S; Sekiya U; Shintani F; Kinoshita N; Yagi G; Asai M
    Biol Psychiatry; 1994 Nov; 36(10):654-61. PubMed ID: 7880934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.
    Duncan E; Wolkin A; Angrist B; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J
    Biol Psychiatry; 1993 Oct; 34(8):523-8. PubMed ID: 8274579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homovanillic acid as a predictor of response to neuroleptics.
    Davila R; Manero E; Zumarraga M; Andia I; Schweitzer JW; Friedhoff AJ
    Arch Gen Psychiatry; 1988 Jun; 45(6):564-7. PubMed ID: 3377643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD; Sanger TM
    Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited.
    Volavka J; Douyon R; Convit A; Czobor P; Cooper TB
    Arch Gen Psychiatry; 1992 Dec; 49(12):999-1000. PubMed ID: 1449388
    [No Abstract]   [Full Text] [Related]  

  • 9. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D; Labarca R; Doran AR; Wolkowitz OM; Roy A; Breier A; Linnoila M; Paul SM
    Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.
    Suzuki E; Kanba S; Koshikawa H; Nibuya M; Yagi G; Asai M
    J Psychiatry Neurosci; 1996 May; 21(3):167-71. PubMed ID: 8935328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients.
    Sharma RP; Javaid JI; Pandey GN; Janicak PG; Davis JM
    Biol Psychiatry; 1991 Sep; 30(5):459-66. PubMed ID: 1657221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R; Zumárraga M; Basterreche N; Arrúe A; Anguiano JB
    Psychiatry Res; 2007 May; 151(1-2):163-8. PubMed ID: 17434602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol response and plasma catecholamines and their metabolites.
    Green AI; Alam MY; Boshes RA; Waternaux C; Pappalardo KM; Fitzgibbon ME; Tsuang MT; Schildkraut JJ
    Schizophr Res; 1993 Jun; 10(1):33-7. PubMed ID: 8369230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mianserin on negative symptoms in schizophrenia.
    Mizuki Y; Kajimura N; Imai T; Suetsugi M; Kai S; Kaneyuki H; Yamada M
    Int Clin Psychopharmacol; 1990 Apr; 5(2):83-95. PubMed ID: 1696292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
    Galinowski A; Poirier MF; Aymard N; Leyris A; Beauverie P; Bourdel MC; Loo H
    Acta Psychiatr Scand; 1998 Jun; 97(6):458-66. PubMed ID: 9669519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive versus negative symptoms in schizophrenia: response to haloperidol.
    Palao DJ; Arauxo A; Brunet M; Marquez M; Bernardo M; Ferrer J; Gonzalez-Monclus E
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):155-64. PubMed ID: 8115670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum homovanillic acid levels in schizophrenic patients and normal control subjects.
    Steinberg JL; Garver DL; Moeller FG; Raese JD; Orsulak PJ
    Psychiatry Res; 1993 Aug; 48(2):93-106. PubMed ID: 8416025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects.
    Magliozzi JR; Doran AR; Gietzen DW; Olson AM; Maclin EL; Tuason VB
    Psychiatry Res; 1993 May; 47(2):141-9. PubMed ID: 8341767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of rapid neuroleptic response in male patients with schizophrenia.
    Petrie EC; Faustman WO; Moses JA; Lombrozo L; Csernansky JG
    Psychiatry Res; 1990 Aug; 33(2):171-7. PubMed ID: 2243894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory and plasma HVA changes in schizophrenia: are they episode markers?
    Gilbertson MW; Yao JK; van Kammen DP
    Biol Psychiatry; 1994 Feb; 35(3):203-6. PubMed ID: 8173021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.